Clinical Trials Browser

Phase 1 × Azurin × Clear all

NCT00914914 2014-10-28

Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment

Phase 1 Completed

Other solid neoplasm

Refractory Solid Tumors